Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Understanding when most people start planning for retirement can help you avoid delays. Find out the trends and best practices for timely planning.
22,030 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Intel leads a high-stakes comeback race among legacy hardware players, while HP and Xerox wrestle with structural hea...
CoreWeave stock moves in a volatile path as a growing backlog and AI partnerships underpin a potential upside. This a...
As AI-driven stocks wobble between skepticism and momentum, HSBC strategists say a turn in valuations could lift pric...
Rising memory costs are pushing Apple to raise prices higher. This article examines how that could affect margins, de...
Europe’s mica regime is now fully in force, bringing a unified licensing framework to the EU. The move reshapes who w...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
A looming 10-year treasury signal could temper SCHD's 2026 rally as rising yields threaten valuations for dividend-fo...
Two blue-chip banks report divergent 2026 results: Morgan Stanley leans on wealth advisory, while JPMorgan runs a uni...
MISMO unveils updates to its Mortgage Insurance Implementation Guide to support VantageScore 4.0 and FICO 10T, aiming...
A new AI-driven forecast highlights two XRP price paths tied to a key CLARITY Act vote, with a possible surge to $5 o...
Owens Corning stock rocked the market this week after rumor-driven buying interest and strong housing data. This guid...